BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 11916004)

  • 21. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; Deen PM
    Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C; Molnár E; Sallay P; Czinner A
    Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrafamilial phenotype variability in nephrogenic diabetes insipidus.
    Kalenga K; Persu A; Goffin E; Lavenne-Pardonge E; van Cangh PJ; Bichet DG; Devuyst O
    Am J Kidney Dis; 2002 Apr; 39(4):737-43. PubMed ID: 11920339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1996 Mar; 54(3):819-24. PubMed ID: 8904243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.
    van den Ouweland AM; Dreesen JC; Verdijk M; Knoers NV; Monnens LA; Rocchi M; van Oost BA
    Nat Genet; 1992 Oct; 2(2):99-102. PubMed ID: 1303271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephrogenic diabetes insipidus.
    Knoers NV; Monnens LL
    Semin Nephrol; 1999 Jul; 19(4):344-52. PubMed ID: 10435672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology of hereditary diabetes insipidus.
    Fujiwara TM; Bichet DG
    J Am Soc Nephrol; 2005 Oct; 16(10):2836-46. PubMed ID: 16093448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
    Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
    Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
    Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA
    Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus.
    Oksche A; Dickson J; Schülein R; Seyberth HW; Müller M; Rascher W; Birnbaumer M; Rosenthal W
    Biochem Biophys Res Commun; 1994 Nov; 205(1):552-7. PubMed ID: 7999078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.